Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “AL Amyloidosis (AL)”

161 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 161 results

Testing effectiveness (Phase 2)Looking for participantsNCT06097832
What this trial is testing

Study of NXC-201 CAR-T in Patients With Light Chain (AL) Amyloidosis

Who this might be right for
Light Chain (AL) Amyloidosis
Nexcella Inc. 40
Testing effectiveness (Phase 2)Study completedNCT01083316
What this trial is testing

Bortezomib and Dexamethasone Followed by High-Dose Melphalan and Stem Cell Transplantation for Primary (AL) Amyloidosis

Who this might be right for
Amyloidosis
Boston Medical Center 35
Testing effectiveness (Phase 2)Looking for participantsNCT06292780
What this trial is testing

A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis)

Who this might be right for
Relapsed/Refractory Systemic Light Chain Amyloidosis
Regeneron Pharmaceuticals 220
Not applicableStudy completedNCT02716103
What this trial is testing

Assessment of Minimal Residual Disease (MRD) After Antineoplastic Treatment in Patients With AL Amyloidosis

Who this might be right for
Amyloidosis
Boston Medical Center 45
Testing effectiveness (Phase 2)UnknownNCT04316442
What this trial is testing

Study of the Safety and Efficacy of STI-6129 in Patients With Relapsed or Refractory Systemic AL Amyloidosis

Who this might be right for
Light Chain (AL) Amyloidosis
Sorrento Therapeutics, Inc. 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT05996406
What this trial is testing

Venetoclax and Dexamethasone for Newly Diagnosed Light-Chain Amyloidosis with Translocation (11;14)

Who this might be right for
Light Chain (AL) AmyloidosisCCND1 TranslocationVenetoclax
Peking Union Medical College Hospital 36
Large-scale testing (Phase 3)Study completedNCT00477971
What this trial is testing

Low-Dose Melphalan and Dexamethasone Compared With High-Dose Melphalan Followed By Autologous Stem Cell Transplant in Treating Patients With Primary Systemic Amyloidosis

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Mayo Clinic 89
Testing effectiveness (Phase 2)Study completedNCT00298766
What this trial is testing

Open-Label Phase 1/2 Study of VELCADE for Injection in Patients With Light-chain (AL)-Amyloidosis

Who this might be right for
Amyloidosis
Millennium Pharmaceuticals, Inc. 70
Testing effectiveness (Phase 2)Study completedNCT05199337
What this trial is testing

Phase 1/2 Study of ZN-d5 for the Treatment of Relapsed or Refractory Light Chain (AL) Amyloidosis

Who this might be right for
AmyloidosisAL Amyloidosis
K-Group Alpha, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc. 18
Large-scale testing (Phase 3)Study completedNCT01277016
What this trial is testing

A Trial for Systemic Light-chain (AL) Amyloidosis

Who this might be right for
AL Amyloidosis
European Myeloma Network B.V. 110
Testing effectiveness (Phase 2)Active Not RecruitingNCT03618537
What this trial is testing

Ixazomib Maintenance Study in Patients With AL Amyloidosis

Who this might be right for
AL Amyloidosis
Memorial Sloan Kettering Cancer Center 17
Not applicableEnrolling By InvitationNCT04210791
What this trial is testing

Autologous Stem Cell Transplantation for Patients With AL Amyloidosis

Who this might be right for
AL AmyloidosisPlasma Cell Dyscrasia
Nanjing University School of Medicine 500
Testing effectiveness (Phase 2)Study completedNCT01570387
What this trial is testing

A Phase I/II Trial of Pomalidomide and Dexamethasone in Subjects With Previously-Treated AL Amyloidosis

Who this might be right for
AL Amyloidosis
Boston Medical Center 27
Testing effectiveness (Phase 2)WithdrawnNCT05486481
What this trial is testing

Venetoclax, Daratumumab, and Dexamethasone for Systemic Light-Chain Amyloidosis With Translocation (11;14) (ALTITUDE)

Who this might be right for
AL AmyloidosisLight Chain (AL) AmyloidosisSystemic Light Chain Disease
Alfred Chung, MD
Testing effectiveness (Phase 2)Study completedNCT05235269
What this trial is testing

Evaluate Organ Level Uptake Repeatability of 124I AT-01 in Subjects With Systemic Amyloidosis

Who this might be right for
Amyloidosis
Attralus, Inc. 33
Early research (Phase 1)Study completedNCT00807872
What this trial is testing

Radioimmunoimaging of AL Amyloidosis

Who this might be right for
Primary Amyloidosis
University of Tennessee 40
Not applicableLooking for participantsNCT01758042
What this trial is testing

Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders

Who this might be right for
Chronic Kidney DiseaseAcute Myeloid Leukemia (AML)Acute Lymphoblastic Leukemia (ALL)+14 more
Massachusetts General Hospital 10
Large-scale testing (Phase 3)Ended earlyNCT04973137
What this trial is testing

Evaluate the Efficacy and Safety of Birtamimab in Mayo Stage IV Patients With AL Amyloidosis

Who this might be right for
Light Chain (AL) Amyloidosis
Prothena Biosciences Ltd. 208
Testing effectiveness (Phase 2)Looking for participantsNCT05066607
What this trial is testing

Isatuximab Plus Pomalidomide and Dexamethasone Association for Patients With AL Amyloidosis Not in VGPR or Better After Any Previous Therapy

Who this might be right for
AL Amyloidosis
Intergroupe Francophone du Myelome 46
Not applicableStudy completedNCT04937777
What this trial is testing

A Study on the Management and Outcome of Patients With Systemic AL Amyloidosis in Europe

Who this might be right for
AL Amyloidosis
European Myeloma Network B.V. 4,481
Load More Results